Gastroenterology
MD, MS, FACS, DABS, FSSO, Director, Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program, Fred Hutchinson Cancer Center, and Program Director, Regional Cancer Therapies, UW Medical Center; Associate Professor and Section Chief, Complex Abdominal…
Harveshp Mogal, MD, MS, FACS, DABS, FSSO, is a board-certified surgical oncologist who specializes in the care of patients with advanced cancers of the abdomen including peritoneal cancers, gastrointestinal neuroendocrine tumors and sarcoma. He is the Director of UW Medical Center and Fred Hutchinson Cancer Center's hyperthermic intraperitoneal chemotherapy (HIPEC) program.
Dr. Mogal is passionate about team-based, multidisciplinary and evidenced-based care of patients. His clinical practice is focused on the surgical care of patients with advanced abdominal cancers including appendix cancer, peritoneal carcinomatosis/ pseudomyxoma peritonei, mesothelioma, sarcoma and gastrointestinal neuroendocrine tumors, including minimally invasive/robotic approaches. He also treats patients with melanoma and other skin cancers.
Dr. Mogal is an Associate Professor in the Department of Surgery at the UW School of Medicine. He conducts clinical research focusing on the outcomes of patients who undergo surgical treatment for peritoneal malignancies and sarcomas. He also serves as the director of regional cancer therapies at UW Medicine.
Selected publications from PubMed
ASO Visual Abstract: Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.
Oppat KM, Bennett FJ, Patel SH, Raoof M, Baumgartner JM, Mogal HD, Lambert LA, Abbott DE, Greer JB, Grotz TE, Fournier KF, Dineen SP, Powers B, Zaidi MY, Winer JH, Russell MC, Staley CA, Cloyd JM, Maithel SK, Concors SJ
Ann Surg Oncol. 2026 Aug 17 doi: 10.1245/s10434-026-20331-x.
Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.
Oppat KM, Bennett FJ, Patel SH, Raoof M, Baumgartner JM, Mogal HD, Lambert LA, Abbott DE, Greer JB, Grotz TE, Fournier KF, Dineen SP, Powers B, Zaidi MY, Winer JH, Russell MC, Staley CA, Cloyd JM, Maithel SK, Concors SJ
Ann Surg Oncol. 2026 Aug 3 doi: 10.1245/s10434-026-20255-6.
Clinicopathologic characteristics of rare appendiceal collision tumors: A multi-center case series and literature review.
Wang JJ, Durowoju L, Masaadeh A, Bosch DE, Zhang X, Karamchandani DM, Cui M, Liu Y, Samraj AN, Swanson PE, Mogal HD, Reddi DM
Ann Diagn Pathol. 2026 Aug;83:152646 doi: 10.1016/j.anndiagpath.2026.152646.
Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application.
Goodsell KE, Carter JA, Abrams HR, Mogal H, Loggers ET, Sharib J
J Surg Oncol. 2026 Sep;134(4):490-501 doi: 10.1002/jso.70326.
Implementing Electronic Health Record-Embedded Screening for Distress and Health-Related Social Needs in Oncology.
McMillen K, Kreizenbeck KL, Go TA, Mogal H, Shannon Dorcy K
Clin J Oncol Nurs. 2025 Nov 19;29(6):484-490 doi: 10.1188/25.CJON.484-490.
The Association of Out Surgeons and Allies (AOSA) is proud to work with the AIS Channel to present a discussion on the diverse experiences of LGBTQI+ surgeons and trainees. In this event, you will hear from trainees and attending surgeons on the challenges of being LGBTQI+ in surgical specialties. We will also discuss what individual allies, departments, and institutions can do to alleviate some of these challenges and foster a supportive environment for LGBTQI+ individuals. We will explore how working towards building an inclusive surgical workforce enriches the working environment and enhances the care of the diverse populations that we serve.
With AOSA
Published
Sep 2024
It is essential that we focus a bright spotlight on diversity, equity and inclusion, to assure that our ''House of Surgery'' welcomes those from all different backgrounds in order to accept and support all surgeons and surgeons in training as they are. The Association of Out Surgeons and Allies (AOSA) is a new affinity group; today we have brought together panelists at all levels of their careers, from resident to Chair of Surgery, to discuss AOSA and also how all of us—AOSA, LGBTQIA+ colleagues and our allies—can work together to best support LGBTQIA+ trainees and faculty and thereby promoting a safe and diverse surgical community.
With Johnson & Johnson MedTech
Published
Nov 2022
Help your network discover Dr. Harveshp Mogal's clinical expertise.
